BERTOLDO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 7.925
EU - Europa 7.464
AS - Asia 5.615
SA - Sud America 851
AF - Africa 153
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 22.028
Nazione #
US - Stati Uniti d'America 7.806
RU - Federazione Russa 2.366
SG - Singapore 2.277
GB - Regno Unito 1.997
CN - Cina 1.639
IT - Italia 811
BR - Brasile 686
VN - Vietnam 504
HK - Hong Kong 460
SE - Svezia 441
FR - Francia 414
DE - Germania 413
FI - Finlandia 350
IE - Irlanda 324
KR - Corea 178
UA - Ucraina 112
IN - India 93
TR - Turchia 84
BD - Bangladesh 69
ID - Indonesia 65
AR - Argentina 58
CA - Canada 55
NL - Olanda 51
JP - Giappone 43
NG - Nigeria 43
MX - Messico 38
AE - Emirati Arabi Uniti 35
ZA - Sudafrica 34
IQ - Iraq 27
EC - Ecuador 26
ES - Italia 25
PL - Polonia 20
BE - Belgio 19
CL - Cile 19
PK - Pakistan 18
RO - Romania 18
AT - Austria 16
PH - Filippine 16
VE - Venezuela 16
CO - Colombia 15
EG - Egitto 15
EE - Estonia 13
AU - Australia 12
CZ - Repubblica Ceca 12
IR - Iran 12
LT - Lituania 12
PY - Paraguay 12
MY - Malesia 11
MA - Marocco 10
UZ - Uzbekistan 10
BJ - Benin 9
JO - Giordania 9
KE - Kenya 9
DZ - Algeria 8
IL - Israele 8
OM - Oman 8
CR - Costa Rica 7
HR - Croazia 7
PE - Perù 7
SK - Slovacchia (Repubblica Slovacca) 7
SA - Arabia Saudita 6
UY - Uruguay 6
BH - Bahrain 5
BO - Bolivia 5
JM - Giamaica 5
PR - Porto Rico 5
TG - Togo 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BG - Bulgaria 4
CH - Svizzera 4
GA - Gabon 4
HU - Ungheria 4
KZ - Kazakistan 4
LB - Libano 4
LV - Lettonia 4
RS - Serbia 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
GE - Georgia 3
SI - Slovenia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
TW - Taiwan 3
AL - Albania 2
AZ - Azerbaigian 2
HN - Honduras 2
IS - Islanda 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
TH - Thailandia 2
AO - Angola 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
Totale 22.005
Città #
Southend 1.775
Singapore 1.201
Jacksonville 979
Chandler 816
San Jose 739
Ashburn 734
Moscow 698
Dallas 604
Hong Kong 448
Ann Arbor 388
Woodbridge 377
Houston 322
Dublin 321
Verona 279
Beijing 211
The Dalles 193
Ho Chi Minh City 166
Princeton 149
Lawrence 148
New York 147
Council Bluffs 140
Wilmington 137
Los Angeles 128
Nanjing 124
Hanoi 109
Jinan 109
Shenyang 97
Buffalo 86
Milan 85
Helsinki 76
Hebei 74
Changsha 69
Sindelfingen 69
Boardman 68
Tianjin 67
São Paulo 63
Munich 54
Nanchang 53
Redondo Beach 51
Ningbo 48
Orem 48
Santa Clara 48
Bologna 45
Zhengzhou 41
Abuja 40
London 40
Tokyo 40
Taizhou 36
Haikou 35
Jakarta 35
Hangzhou 33
Jiaxing 33
Chicago 31
San Francisco 31
Rome 29
Columbus 28
Da Nang 28
Dearborn 27
Guangzhou 26
Lancaster 24
Frankfurt am Main 23
Rio de Janeiro 22
Montreal 21
Falls Church 19
Johannesburg 19
Turku 19
Atlanta 18
Haiphong 18
Norwalk 18
Amsterdam 17
Fuzhou 17
Paris 17
Phoenix 17
Seoul 17
Brooklyn 16
Brussels 16
Chennai 16
Detroit 16
Dong Ket 16
Mexico City 16
Stockholm 16
Taiyuan 16
Curitiba 15
Denver 15
Lappeenranta 15
Seattle 15
Warsaw 15
Belo Horizonte 14
Biên Hòa 14
Boston 13
Dhaka 13
Manchester 13
Mumbai 13
Redmond 12
Washington 12
Brasília 11
Fairfield 11
Falkenstein 11
Lanzhou 11
Nuremberg 11
Totale 13.724
Nome #
Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro. 278
The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation 270
Gene expression analysis in osteoblastic differentiation from peripheral blood mesenchymal stem cells 258
Adipocytes IGFBP-2 expression in prepubertal obese children. 253
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 244
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 243
The effects on hTERT gene expression is an additional mechanism of amino-bisphosphonates in prostatic cancer cells 241
Age-related bone loss in postmenopausal women 237
STEAP mRNA detection in serum of patients with solid tumours. 234
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 233
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 232
Bone metabolism in patients with anorexia nervosa and amenorrhoea 226
Type VI Osteogenesis imperfecta: effect of plasma transfusion on bone metabolism 224
Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats. 219
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 216
BISPHOSPHONATES DECREASE HTERT IN PC3 AND DU-145 PROSTATE CANCER CELLS 214
A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: Prednisone versus Deflazacort. 211
Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control study. 202
Incidenza di ipovitaminosi D nel Nord Italia 198
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 195
Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020 192
Histomorphometric analysis of glucocorticoid-induced osteoporosis 191
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 191
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 190
Altered bone metabolism in children infected with human immunodeficiency virus. 189
Bone development during GH and GnRH analog treatment 188
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 185
Bone microarchitecture evaluated by histomorphometry 184
[Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures]. 178
The effect of bisphosphonates on gene expression: GAPDH as a housekeeping or a new target gene? 176
Bisphosphonates and osteonecrosis of the mandible/maxilla in osteoporosis: no reason to panic 175
Guidelines for the diagnosis, prevention and management of osteoporosis 175
Blood ionized calcium is associated with clustered polymorphism in the carboxyl-terminal tail of the calcium-sensing receptor. 174
ARTROPATIE DISMETABOLICHE 170
Prevalence of asymptomatic vertebral fractures in late-onset Pompe disease. 170
Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment 167
Acute effects of deflazacort and prednisone on rates of mineralization and bone formation 165
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 165
Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment 164
Bisfosfonati e metastasi ossee:up-to-date 2005 163
Bone Microarchitecture in Mild Primary Hyperparathyroidism 161
emerging drugs for the management of cancer treatment induced bone loss 161
Osteopenia induced by immunosuppressive drugs in rats. Histomorphometric analisys of risedronate effects. 156
[Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project] 156
GAPDH: CONSTITUTIVE HOUSEKEEPING GENE OR TARGET FOR THERAPEUTIC INTERVENTION? 155
Artropatie dismetaboliche 155
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 155
Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle. 153
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 150
Drug-induced osteonecrosis of the jaw: the state of the art 150
Effects of a 4400 km ultra-cycling non-competitive race and related training on body composition and circulating progenitors differentiation 149
Impact of the Visceral Adipose Tissue on Bone Quality in Patients with Untreated mild-to-severe Obstructive Sleep Apnoea 149
The renal handling of calcium: influence of parathyroid hormone secretion 149
Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation. 149
Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO) 148
Biology and Pathophysiology of Bone Metastasis in Prostate Cancer 146
YEARS BOOK 2006 . BISFOSFONATI E ONCOLOGIA 143
Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism. 143
Post-diagnosis serum 25-hydroxyvitamin D concentrations in women treated for breast cancer participating in a lifestyle trial in Italy 142
Incidenza di ipovitaminosi D nel Nord Italia 142
Effects of two oral doses of alendronate in the treatment of Paget's disease of bone 141
PEAK BONE MASS AND BODY COMPOSITION IN PRECOCIOUS PUBERTY AFTER GNRH AGONIST THERAPY WITH AND WITHOUT CALCIUM SUPPLEMENTATION 141
Predictive role of changes in the tumor burden and International Metastatic Renal Cell Carcinoma Database Consortium class during active surveillance for metastatic renal cell carcinoma 141
Osteomalacia: The missing link in the pathogenesis of Bisphosphonate-related osteonecrosis of the jaws? 140
Bone Mineral Density in Mountain, Road Cyclists and Untrained Controls: Exercise, Diet and Hormones 139
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 139
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 139
CALCIUM SUPPLEMENTATION, OESTROGENS AND BONE DENSITY IN GNRHA TREATED PRECOCIOUS PUBERTY 138
EFFETTO DI UN AGONISTA DEL GNRH AD AZIONE PROLUNGATA (LEUPROLIDE ACETATO) SULLO STATO DI MINERALIZZAZIONE OSSEA IN BAMBINE CON PUBERTA' PRECOCE 136
Bone mineral density and metabolism in HIV-infected children 136
Valutazione della microarchitettura ossea nell'iperparatiroidismo primitivo 135
Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism. 135
The prevention of corticosteroid-induced osteoporosis with nandrolone decantate Bone and Mineral 15, 72-81 (1991) 134
Regulation of calcium-parathyroid hormone feedback in primary htperparathyroidism effcts of bisphosphonate treatment 133
Physiopatology of bone metastases 133
the use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemnia of malignanacy 132
Transdermal Estradiol in the treatment of postmenopausale bone loss. 132
The use of dichloromethylene bisphosphonate and aminobutanebisphosphonate in hypercalcemia of malignancy. 132
The epidemiology of osteoporosis in Italian postmenopausal women according to the National Bone Health Alliance (NBHA) diagnostic criteria: a multicenter cohort study 129
Transdermal estradiol in the treatment of postmenopausal bone loss. 127
Serum 25-hydroxy vitamin D and exercise capacity in COPD. 127
Final peak bone mass in precocious puberty after GhRH agonist therapy with and without calcium supplementation 126
The Effect of Bisphosphonates on Gene Expression: The GAPDH as a Housekeeping or a New Target Gene? 126
Calcium Supplementation Increases Bone Mass in GH-Deficient Prepubertal Children during GH Replacement 126
Effects of two oral doses of alendronate in the treatment of Paget’s disease of bone. 126
Sodium requirements regulates renal tubular reabsorption of calcium 125
Relationship between serum calcium, sodium excretion and calcium excretion in normals and in patients with idiopathic hypercalcemia and with primary hyperparathyroidism 124
intramuscolar neridronate in postmenopausal women with low bone mineral density 124
Treatment thresholds for osteoporosis and reimbursability criteria: perspectives associated with fracture risk-assessment tools. 124
Comment on Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary 124
Effetto dell'alendronato sulle caratteristiche strutturali e biomeccaniche dell'osso corticale 123
A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesis 122
Ruolo dei bisfosfonati nella terapia dell'osteoporosi 121
HIV-infected children and bone mineral density 119
Relationship between serum calcium, sodium excretion and calcium excretion in normals and in patients with idiophatic hypercalciuria and primary hyperparathyroidism 119
Italian position paper (SIPMO-SICMF) on medication-related osteonecrosis of the jaw (MRONJ) 119
Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteopororis fractures 117
Bone metastases in soft tissue sarcoma: a survey of natural history, prognostic value and treatment options. 117
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 116
Trabecular bone microarchitecture in mild primary hyperparathyroidism 116
Totale 16.345
Categoria #
all - tutte 74.440
article - articoli 65.848
book - libri 1.231
conference - conferenze 3.693
curatela - curatele 0
other - altro 253
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.415
Totale 148.880


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202138 0 0 0 0 0 0 0 0 0 0 0 38
2021/20221.251 96 389 6 101 48 48 14 61 39 27 122 300
2022/20232.308 218 196 274 364 227 524 12 134 240 24 73 22
2023/20241.191 53 89 131 135 170 169 59 74 7 50 159 95
2024/20253.153 188 199 113 478 170 75 182 184 461 228 213 662
2025/20268.619 640 469 763 1.356 2.035 550 813 493 759 401 172 168
Totale 22.192